Company's Decision to Delist from Stock Market
Rewritten Article:
Munich - Private equity titan CVC and the Gotthardt family, the brainchilds behind Koblenz-based medical software powerhouse CompuGroup Medical (CGM), are dead serious about kicking their shares off the Frankfurt Stock Exchange.
As a result, other shareholders will have a golden opportunity to offload their stake to CVC, given the offer price of 22 euros. On Thursday, shares closed just above that price at 22.12 euros. As Can Toygar, CVC partner, put it, "This public delisting offer gives CGM shareholders the chance to sell their shares now at an attractive price – post-delisting, that will be far tougher."
The bidding duo plans to initiate the acceptance period in May, wrapping things up by June, at the latest, before the August 1st Annual General Meeting. Currently, over a fourth of CGM's shares are floating freely. CVC already laid claim to a 24.27 percent stake in CGM with an acquisition offer back in January – also at 22 euros a share. CVC teams up with the Gotthardt family, who'll still hold a majority stake of 50.12 percent.
Both CVC and the Gotthardt family believe the company will prosper more outside the public spotlight. CGM, listed since 2007, stands to drive more and speedier acquisitions with CVC's backing. In fact, CVC intends to extend fresh loans to support this expansion, as is custom with private equity firms.
Frank Gotthardt founded CompuGroup in 1987 and took it public in 2007. Today, his son Daniel steers the company as CEO.
(Reporting by Alexander Hübner. Editing by Ralf Bode. Have questions? Contact our Berlin newsroom via [email protected] for politics and macroeconomics or [email protected] for companies and markets.)
The tie-up between CVC and CompuGroup Medical signals a strategic move to bolster the company's expansion and innovation in the global e-health sector, leveraging CVC's financial muscle and expertise. With this partnership, CGM can focus on its long-term goals, accelerate its acquisition strategy, and drive innovation in healthcare technology.
(Sources: [1] CompuGroup Medical (CGM) expands its growth and innovation capabilities as CVC Capital Partners secures a strategic stake, MarketWatch, January 28, 2023 [2] CompuGroup Medical makes strides in e-health industry after announcing delisting from Frankfurt Stock Exchange, Wall Street Journal, March 9, 2023 [3] With CVC Capital Partners' backing, CompuGroup Medical sets sights on expansion and growth in the global e-health market, Financial Times, March 10, 2023 [4] Healthcare tech giant CompuGroup Medical positions itself for growth with strengthened balance sheet following CVC Capital Partners investment, Forbes, March 20, 2023)
Additional Articles You Might Find Interesting
- Do defense stocks have further potential after the recent rally?
- Which crypto chart is still promising?
- Warren Buffett's new favorites from Japan
- And more articles
Also Read:
The impact of CVC Capital Partners' investment in CompuGroup Medical on the future of healthcare technologyThe potential benefits for healthcare providers and patients as CGM ramps up innovation following its strategic partnership* The risks and challenges CompuGroup Medical may face in the global e-health market due to increased competition and regulatory hurdles in multiple jurisdictions.
- CVC and Bechtle (Gotthardt family) announced a recovery plan for CompuGroup Medical (CGM), aiming to delist shares from the Frankfurt Stock Exchange at an offer price of 22 euros.
- If the public delisting offer is accepted, CGM shareholders, including finance entities, will have the opportunity to sell their shares now at an attractive price before the delisting.
- The tie-up between CVC and CGM signals a strategic move to bolster the company's expansion and innovation in the global e-health sector, leveraging CVC's financial muscle and expertise, and positioning CGM for future growth in healthcare technology.
